Skip to main content
. 2015 Jun 4;4(8):1214–1223. doi: 10.1002/cam4.476

Figure 2.

Figure 2

Kaplan–Meier analysis of overall survival (OS) and progression-free survival (PFS) using two different therapeutic regimens in the HAIC group. (A) There was no significant difference in the OS between the LFP group and the IFN-α + 5-FU group (P = 0.900). (B) There was no significant difference in the PFS between the LFP group and the IFN-α + 5-FU group (P = 0.809). HAIC, hepatic arterial infusion chemotherapy; LFP group, patients were treated by low-dose cisplatin + 5-FU hepatic arterial infusion chemotherapy; IFN-α + 5-FU group, patients were treated by subcutaneous interferon-α + 5-FU hepatic arterial infusion chemotherapy.